pfizer glp-1 news scraps daily weight loss pill danuglipron after a liver injury Pfizer is pulling back the

Before your next month, complete a short returning-patient consultation so the prescriber can monitor progress, adjust dose, and, if needed, add side-effect treatments

Not every patient needs this, but for patients with significant muscle mass concerns older adults, perimenopausal women, patients losing weight quickly at high doses it is worth considering

4 and Extended Data Table 3)

found that 52 weeks of once-weekly semaglutide (the active ingredient in Ozempic and Wegovy) reduced hip bone mineral density by 2.6% and lumbar spine density by 2.1% compared to placebo in adults with increased fracture risk

Astrup, A